`
Thursday, 17 August 2017

Clinical Research News

  • Vedic launches ACElerator client-CRO model

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 16 Oct, 2012

    Singapore: Vedic Lifesciences launched an innovative and unique client-CRO model, called ACElerator, for conducting human studies to substantiate product claims. Under this initiative, Vedi...Read more

  • Viralytics accelerates patient recruitment for Cavatak trial

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013

    Singapore: Patient recruitment in phase II CALM trial has accelerated significantly in the past three months with 25 patients now enrolled. Viralytics, which is conducting the trial, said ...Read more

  • AtCor Medical wins $3.2 mn contract

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 08 Oct, 2012

    Singapore: AtCor Medical, developer and marketer of the SphygmoCor system which measures central aortic blood pressures and arterial stiffness non-invasively, has signed a contract to suppl...Read more

  • JCDC receives human research protection accreditation in India

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2012

    Bangalore: The Association for the Accreditation of Human Research Protection Programs, announced that it has accredited a third organization in India, Jehangir Clinical Development Cent...Read more

  • RCC Labs gets exclusive marketing rights from ViruSure

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 01 Nov, 2012

    Bangalore: RCC Laboratories, a Hyderabad based contract research organization (CRO) and ViruSure entered into a partnership to market the services of ViruSure in India. Through this partner...Read more

  • Quintiles, dabl to advance cardiovascular safety

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 05 Oct, 2012

    Singapore: Quintiles and dabl, a provider of centralized ambulatory blood pressure measurement (ABPM) services, have entered into a strategic alliance by which Quintiles' customers worldw...Read more

  • Alchemia cancer trial gets nod from drug safety board

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2012

    Singapore: Alchemia announced that the independent Data Safety Monitoring Board (DSMB) responsible for reviewing the safety data of Alchemia's phase III, double blind, randomized, pivotal ...Read more

  • Pusey is new president, GM of WuXiPRA China

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013

    Singapore: China-based WuXiPRA, a contract research organization (CRO), has appointed Mr James Pusey, as president and general manager. Dr Pusey has more than 25 years of experience in medi...Read more

  • What the future holds for the APAC CRO market?

    Clinical Research |  Analysis | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Perceptive opens customer care office in China

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2012

    Singapore: Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International, has opened a customer care office in Shanghai to service biopharmaceuti...Read more

  • Trifecta joins clinical research training consortium

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 20 Nov, 2012

    Singapore: Trifecta Clinical joined the board of directors for the Asia Training Consortium (ATC), which is a group of pharmaceutical companies, clinical research organizations and regiona...Read more

  • India's clinical trial industry should look into the mirror

    Clinical Research |  Opinion | By Narayanan Suresh | 0 Comment | 12 Jul, 2013

    What are the major issues confronting India's bioscience sector now? On top of every one's mind is the uncertainty over parliamentary approval to the new biotech regulatory legislation and ...Read more

  • Roche starts phase III trial of its eye drug

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2014

    Singapore: Swiss drugmaker Roche announced that it has started late-stage trials of its experimental drug, Lampalizumab. The drug is to be used in the treatment of Geographic Atrophy (GA),...Read more

  • PharmaNet/i3 wins award for oncology research

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 08 Jun, 2012

    Singapore: PharmaNet/i3, inVentiv Health's clinical segment, and a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device compan...Read more

  • Abuse of clinical trial laws need to be prevented

    Clinical Research |  Opinion | By BioSpectrum Bureau | 0 Comment | 15 Oct, 2012

    Clinical trial is a process which involves testing of efficacy of drugs for the purpose of determination of safety, proper dosage range and side effects, prior to the drug being certified a...Read more

  • US state pays PRA $0.4 mn for creating jobs

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 10 May, 2013

    Singapore: PRA, a leading clinical research organization, has received a $400,000 grant from the Kansas Bioscience Authority (KBA) to create 80 new jobs this year in Kansas, US. The gradua...Read more

  • Marken enters S. Korea

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012

    Singapore, June 8, 2012: Global clinical supply chain service provider, Marken has opened its first office in South Korea. The office will manage customer service operations and offer local...Read more

  • RedHill Biopharma announces dosing of first patient in the phase III study with RHB-104 for Crohn’s Disease

    Clinical Research |  News | 0 Comment | 22 Mar, 2017

    RedHill Biopharma Ltd., a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small mole...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls